Deloitte in Albania   Deloitte in Albania
 
 
 
Life Sciences & Health Care

Our Life Sciences & Health Care industry specialists provide extensive knowledge and experience on a range of current issues. Growing customer needs, revolution in R&D and drug discovery, shifting markets and sources, evolution of the biotech sector, emergence of specialty and generic sectors, worldwide efforts to control healthcare costs and an evolving regulatory and compliance environment create both opportunities and challenges for life sciences companies.

Life Sciences

Managing Pathways to Convergence in the Life Sciences Industry
In the life sciences industry, convergence is defined as the integration of two or more core technologies (diagnostics, devices, and/or drugs*) to create an improved health care product.

Innovation in Life Industry

Innovation in Life Industry
Bob Go, Global Managing Director of Deloitte’s Life Sciences and Health Care Industry Group presented two papers at the 2007 World Economic Forum annual meeting. These papers examine innovation in the sector, including key trends and the opinions of top life sciences executives.

Government, Business Must Prepare

Gonvernment, Business Must Prepare Today to Combat Flu Pandemic's Threats
Prepare for the tensions that are expected to cause ripple effects throughout our health system.

More
Contact us for more information about this topic.
 
 
 
     

© 2008 Deloitte Touche Tohmatsu. All rights reserved.

Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu and its Member Firms.

Deloitte RSS Feeds